Gilead (GILD 0.58%) will be reporting 4Q earnings on Monday, as well as the company's full 2012 results. In this video, Motley Fool health-care analyst David Williamson tells us why it has been a transformational year for the company, and what key things to watch for in the upcoming earnings report.
Foolish Preview: Gilead Earnings
By Dave Williamson – Jan 31, 2013 at 5:51PM
NASDAQ: GILD
Gilead Sciences
Market Cap
$147B
Today's Change
(-0.58%) $0.69
Current Price
$118.15
Price as of November 10, 2025 at 4:00 PM ET
A look ahead at what we can expect from Gilead.
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Follow @motleydavid